ArticlePublic health challenges2025
Understanding Long COVID Among Young People in Victoria, Australia: Prevalence, Impact, and Associated Factors.
Article in Public health challenges, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Understanding Long COVID Among Young People in Victoria, Australia: Prevalence, Impact, and Associated Factors.Public health challenges · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Long COVID is a significant public health concern. This study aimed to identify the prevalence, impact, and factors associated with long COVID among young people in Victoria, Australia. Methods: From April to June 2023, we conducted a cross-sectional online survey of people aged 15-29 years. Participants reported if they had ever experienced long COVID (defined as COVID-19 symptoms for more than 4 weeks) and the impact on their daily functioning. We used multivariable logistic regression to compare participants who reported long COVID with participants who reported acute COVID-19. Results: Among 765 participants, 11.2% reported they had ever had long COVID; however, only 1 in 10 had been diagnosed by a medical practitioner. Compared to those without prolonged symptoms, participants reporting long COVID were younger (adjusted odds ratio [aOR]: 0.92; 95% confidence interval [CI]: 0.85-0.99), reported worsened general health (aOR: 8.22; 95% CI: 4.34-15.56), expressed greater concern about getting long COVID again (aOR: 1.20; 95% CI: 1.09-1.33), and had more family or friends who also experienced long COVID (aOR: 4.43; 95% CI: 1.92-10.19). In the past 4 weeks, 79.1% of participants with current long COVID reported difficulties with performing work, and 79.1% accomplished less than desired. Conclusions: One in 10 participants aged 15-29 years experienced long COVID, and most reported negative impacts on their daily life. General practitioners should be aware of the high burden of suspected long COVID in young people and consider supports to mitigate its effects on the health and well-being of this population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.